Sagimet Biosciences Inc (NASDAQ: SGMT) on Friday, soared 16.32% from the previous trading day, before settling in for the closing price of $4.78. Within the past 52 weeks, SGMT’s price has moved between $1.73 and $7.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -74.49%. With a float of $23.62 million, this company’s outstanding shares have now reached $30.67 million.
The firm has a total of 14 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sagimet Biosciences Inc (SGMT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sagimet Biosciences Inc is 26.63%, while institutional ownership is 36.23%. The most recent insider transaction that took place on Jul 23 ’24, was worth 74,830. In this transaction Executive Chairman of this company sold 23,625 shares at a rate of $3.17, taking the stock ownership to the 118,693 shares. Before that another transaction happened on Jul 19 ’24, when Company’s Chief Medical Officer sold 8,357 for $3.10, making the entire transaction worth $25,910. This insider now owns 81,213 shares in total.
Sagimet Biosciences Inc (SGMT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -74.49% per share during the next fiscal year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Sagimet Biosciences Inc (SGMT) is currently performing well based on its current performance indicators. A quick ratio of 20.26 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -3.08 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Analysing the last 5-days average volume posted by the [Sagimet Biosciences Inc, SGMT], we can find that recorded value of 6.37 million was better than the volume posted last year of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 79.11%. Additionally, its Average True Range was 0.44.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 97.70%, which indicates a significant increase from 96.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 96.73% in the past 14 days, which was lower than the 102.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.13, while its 200-day Moving Average is $4.06. Now, the first resistance to watch is $5.92. This is followed by the second major resistance level at $6.27. The third major resistance level sits at $6.90. If the price goes on to break the first support level at $4.94, it is likely to go to the next support level at $4.31. Now, if the price goes above the second support level, the third support stands at $3.96.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
Market capitalization of the company is 170.55 million based on 30,675K outstanding shares. Right now, sales total 0 K and income totals -45,570 K. The company made 0 K in profit during its latest quarter, and -18,180 K in sales during its previous quarter.
